Skip to main content
SpringerLink
Log in

Nuclear Transcription Factor-κB: A Drug Target for all Seasons

  • Chapter
Book cover Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases

To whom correspondence should be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

9. References

  • Abbadie C, Kabrun N, Bouali F, et al., (1993). High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell, 75:899–912.

    PubMed  CAS  Google Scholar 

  • Abu-Amer Y, Dowdy SF, Ross FP, et al., (2001). TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J Biol Chem, 276:30499–503.

    PubMed  CAS  Google Scholar 

  • Adams J. (2002). Proteasome inhibitors as new anticancer drugs. Curr Opin Oncol, 14:628–34.

    PubMed  CAS  Google Scholar 

  • Aggarwal BB, Kumar A & Bharti AC. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res, 23:363–98.

    PubMed  CAS  Google Scholar 

  • Arlt A, Gehrz A, Muerkoster S, et al., (2003). Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene, 22:3243–51.

    PubMed  CAS  Google Scholar 

  • Arsura M, Wu M & Sonenshein GE. (1996). TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity, 5:31–40.

    PubMed  CAS  Google Scholar 

  • Auphan N, DiDonato JA, Rosette C, et al., (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science, 270:286–90.

    PubMed  CAS  Google Scholar 

  • Badawi AF & Badr MZ. (2002). Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma. Int J Oncol, 20:1109–22.

    PubMed  CAS  Google Scholar 

  • Baeuerle PA & Baichwal VR. (1997). NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol, 65:111–37.

    PubMed  CAS  Google Scholar 

  • Bakker TR, Reed D, Renno T, et al., (1999). Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int J Cancer, 80:320–3.

    PubMed  CAS  Google Scholar 

  • Bales KR, Du Y, Dodel RC, et al., (1998). The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res, 57:63–72.

    PubMed  CAS  Google Scholar 

  • Bargou RC, Emmerich F, Krappmann D, et al., (1997). Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin’s disease tumor cells. J Clin Invest, 100:2961–9.

    PubMed  CAS  Google Scholar 

  • Bargou RC, Leng C, Krappmann D, et al., (1996). High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood, 87:4340–7.

    PubMed  CAS  Google Scholar 

  • Barkett M & Gilmore TD. (1999). Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene, 18:6910–24.

    PubMed  CAS  Google Scholar 

  • Barth TF, Dohner H, Werner CA, et al., (1998). Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood, 91:4321–30.

    PubMed  CAS  Google Scholar 

  • Bash J, Zong WX & Gelinas C. (1997). c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the Gl/S-phase transition. Mol Cell Biol, 17:6526–36.

    PubMed  CAS  Google Scholar 

  • Basu S, Rosenzweig KR, Youmell M, et al., (1998). The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem Biophys Res Commun, 247:79–83.

    PubMed  CAS  Google Scholar 

  • Batra RK, Guttridge DC, Brenner DA, et al., (1999). IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. Am J Respir Cell Mol Biol, 21:238–45.

    PubMed  CAS  Google Scholar 

  • Beg AA & Baltimore D. (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science, 274:782–4.

    PubMed  CAS  Google Scholar 

  • Beg AA, Sha WC, Bronson RT, et al., (1995a). Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev, 9:2736–46.

    PubMed  CAS  Google Scholar 

  • Beg AA, Sha WC, Bronson RT, et al., (1995b). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature, 376:167–70.

    PubMed  CAS  Google Scholar 

  • Bentires-Alj M, Hellin AC, Ameyar M, et al. (1999). Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs. Cancer Res, 59:811–5.

    PubMed  CAS  Google Scholar 

  • Bharti AC & Aggarwal BB. (2002a). Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Ann NY Acad Sci, 973:392–5.

    PubMed  CAS  Google Scholar 

  • Bharti AC & Aggarwal BB. (2002b). Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol, 64:883–8.

    PubMed  CAS  Google Scholar 

  • Bharti AC, Donato N, Singh S, et al., (2003). Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101:1053–62.

    PubMed  CAS  Google Scholar 

  • Biswas DK, Martin KJ, McAlister C, et al., (2003). Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res, 63:290–5.

    PubMed  CAS  Google Scholar 

  • Boothby MR, Mora AL, Scherer DC, et al., (1997). Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med, 185:1897–907.

    PubMed  CAS  Google Scholar 

  • Bours V, Dejardin E, Goujon-Letawe F, et al., (1994). The NF-kappa B transcription factor and cancer: high expression of NF-kappa B-and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol, 47:145–9.

    PubMed  CAS  Google Scholar 

  • Brach MA, Hass R, Sherman ML, et al., (1991). Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest, 88:691–5.

    PubMed  CAS  Google Scholar 

  • Brostjan C, Anrather J, Csizmadia V, et al., (1996). Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem, 271:19612–6.

    PubMed  CAS  Google Scholar 

  • Caamano JH, Rizzo CA, Durham SK, et al., (1998). Nuclear factor (NF)-kappa B2 (pl00/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med, 187:185–96.

    PubMed  CAS  Google Scholar 

  • Cabannes E, Khan G, Aillet F, et al., (1999). Mutations in the IkBa gene in Hodgkin’s disease suggest a tumour suppressor role for IkappaBalpha. Oncogene, 18:3063–70.

    PubMed  CAS  Google Scholar 

  • Cadoret A, Bertrand F, Baron-Delage S, et al., (1997). Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. Oncogene, 14:1589–600.

    PubMed  CAS  Google Scholar 

  • Camandola S & Mattson MP. (2000). Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J Neurosci Res, 61:134–9.

    PubMed  CAS  Google Scholar 

  • Cao Z, Tanaka M, Regnier C, et al., (1999). NF-kappa B activation by tumor necrosis factor and interleukin-1. Cold Spring Harb Symp Quant Biol, 64:473–83.

    PubMed  CAS  Google Scholar 

  • Chakraborty M, Qiu SG, Vasudevan KM, et al., (2001). Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res, 61:7255–63.

    PubMed  CAS  Google Scholar 

  • Chan H, Bartos DP & Owen-Schaub LB. (1999). Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol Cell Biol, 19:2098–108.

    PubMed  CAS  Google Scholar 

  • Chapman NR & Perkins ND. (2000). Inhibition of the RelA(p65) NF-kappaB subunit by Egr-l. J Biol Chem, 275:4719–25.

    PubMed  CAS  Google Scholar 

  • Chaturvedi MM, Kumar A, Darnay BG, et al., (1997). Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem, 272:30129–34.

    PubMed  CAS  Google Scholar 

  • Chen E & Li CC. (1998). Association of Cdk2/cyclin E and NF-kappa B complexes at Gl/S phase. Biochem Biophys Res Commun, 249:728–34.

    PubMed  CAS  Google Scholar 

  • Chen FE & Ghosh G. (1999). Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene, 18:6845–52.

    PubMed  CAS  Google Scholar 

  • Chen L, Fischle W, Verdin E, et al., (2001). Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science, 293:1653–7.

    CAS  Google Scholar 

  • Chuang SE, Yeh PY, Lu YS, et al., (2002). Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol, 63:1709–16.

    PubMed  CAS  Google Scholar 

  • Cogswell PC, Mayo MW & Baldwin AS, Jr. (1997). Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa Bl transcription. J Exp Med, 185:491–7.

    PubMed  CAS  Google Scholar 

  • Cusack JC, Jr., Liu R & Baldwin AS, Jr. (2000). Inducible chemoresistance to 7-ethyl-10-[4-(l-piperidino)-l-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation. Cancer Res, 60:2323–30.

    PubMed  CAS  Google Scholar 

  • Cusack JC, Jr., Liu R, Houston M, et al., (2001). Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res, 61: 3535–40.

    PubMed  CAS  Google Scholar 

  • D’Acquisto F, Ialenti A, Ianaro A, et al., (2000). Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw. GeneTher, 7:1731–7.

    CAS  Google Scholar 

  • Delgado M, Munoz-Elias EJ, Kan Y, et al., (1998). Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun. J Biol Chem, 273:31427–36.

    PubMed  CAS  Google Scholar 

  • DeMeester SL, Qiu Y, Buchman TG, et al., (1998). Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med, 26:1500–9.

    PubMed  CAS  Google Scholar 

  • Diaz-Meco MT, Lallena MJ, Monjas A, et al., (1999). Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J Biol Chem, 274:19606–12.

    PubMed  CAS  Google Scholar 

  • Doi TS, Takahashi T, Taguchi O, et al., (1997). NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgGl and reduced proliferative responses. J Exp Med, 185:953–61.

    PubMed  CAS  Google Scholar 

  • Dumont A, Hehner SP, Hofmann TG, et al., (1999). Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene, 18:747–57.

    PubMed  CAS  Google Scholar 

  • Ehrlich LC, Hu S, Peterson PK, et al., (1998). IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. Neuroreport, 9:1723–6.

    PubMed  CAS  Google Scholar 

  • Epinat JC & Gilmore TD. (1999). Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway. Oncogene, 18:6896–909.

    PubMed  CAS  Google Scholar 

  • Erl W, Hansson GK, de Martin R, et al., (1999). Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res, 84:668–77.

    PubMed  CAS  Google Scholar 

  • Esslinger CW, Jongeneel CV & MacDonald HR. (1998). Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation. Mol Immunol, 35: 47–52.

    Google Scholar 

  • Feinman R, Koury J, Thames M, et al., (1999). Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood, 93:3044–52.

    PubMed  CAS  Google Scholar 

  • Fenteany G & Schreiber SL. (1998). Lactacystin, proteasome function, and cell fate. J Biol Chem, 273:8545–8.

    PubMed  CAS  Google Scholar 

  • Fiedler MA, Wernke-Dollries K & Stark JM. (1996). Inhibition of viral replication reverses respiratory syncytial virus-induced NF-kappaB activation and interleukin-8 gene expression in A549 cells. J Virol, 70:9079–82.

    PubMed  CAS  Google Scholar 

  • FitzGerald MJ, Webber EM, Donovan JR, et al., (1995). Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ, 6:417–27.

    PubMed  CAS  Google Scholar 

  • Folkman J. (1993). Diagnostic and therapeutic applications of angiogenesis research. C R Acad Sci III, 316:909–18.

    PubMed  CAS  Google Scholar 

  • Frantz B, Nordby EC, Bren G, et al., (1994). Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J, 13:861–70.

    PubMed  CAS  Google Scholar 

  • Frantz B & O’Neill EA. (1995). The effect of sodium salicylate and aspirin on NF-kappa B. Science, 270:2017–9.

    PubMed  CAS  Google Scholar 

  • Franzoso G, Carlson L, Poljak L, et al., (1998). Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med, 187:147–59.

    PubMed  CAS  Google Scholar 

  • Gabrilovich D, Ishida T, Oyama T, et al., (1998). Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92:4150–66.

    PubMed  CAS  Google Scholar 

  • Garg AK & Aggarwal BB. (2002). Reactive oxygen intermediates in TNF signaling. Mol Immunol, 39:509–17.

    PubMed  CAS  Google Scholar 

  • Gerbes AL, Vollmar AM, Kiemer AK, et al., (1998). The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology, 28:1309–17.

    PubMed  CAS  Google Scholar 

  • Gerondakis S, Grossmann M, Nakamura Y, et al., (1999). Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene, 18:6888–95.

    PubMed  CAS  Google Scholar 

  • Giri DK & Aggarwal BB. (1998). Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem, 273:14008–14.

    PubMed  CAS  Google Scholar 

  • Grigoriadis G, Zhan Y, Grumont RJ, et al., (1996). The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J, 15:7099–107.

    PubMed  CAS  Google Scholar 

  • Grisham MB, Palombella VJ, Elliott PJ, et al., (1999). Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. Methods Enzymol, 300:345–63.

    PubMed  CAS  Google Scholar 

  • Grumont RJ, Rourke IJ & Gerondakis S. (1999). Rel-dependent induction of Al transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev, 13:400–11.

    PubMed  CAS  Google Scholar 

  • Grumont RJ, Rourke IJ, O’Reilly LA, et al., (1998). B lymphocytes differentially use the Rel and nuclear factor kappaBl (NF-kappaB 1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med, 187:663–74.

    PubMed  CAS  Google Scholar 

  • Guttridge DC, Albanese C, Reuther JY, et al., (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin Dl. Mol Cell Biol, 19:5785–99.

    PubMed  CAS  Google Scholar 

  • Houldsworth J, Mathew S, Rao PH, et al., (1996). REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood, 87:25–9.

    PubMed  CAS  Google Scholar 

  • Hsu H, Shu HB, Pan MG, et al. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84: 299–308.

    PubMed  CAS  Google Scholar 

  • Hu Y, Baud V, Delhase M, et al., (1999). Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science, 284:316–20.

    PubMed  CAS  Google Scholar 

  • Iademarco MF, McQuillan JJ, Rosen GD, et al., (1992). Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem, 267:16323–9.

    PubMed  CAS  Google Scholar 

  • Iimuro Y, Nishiura T, Hellerbrand C, et al., (1998). NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest, 101:802–11.

    PubMed  CAS  Google Scholar 

  • Jang IK, Lee ZH, Kim YJ, et al., (1998). Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. Biochem Biophys Res Commun, 242:613–20.

    PubMed  CAS  Google Scholar 

  • Jefferies C, Bowie A, Brady G, et al., (2001). Transactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Racl. Mol Cell Biol, 21:4544–52.

    PubMed  CAS  Google Scholar 

  • Ji C, Kozak KR & Marnett LJ. (2001). IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J Biol Chem, 276:18223–8.

    PubMed  CAS  Google Scholar 

  • Jimi E, Nakamura I, Ikebe T, et al., (1998). Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem, 273:8799–805.

    PubMed  CAS  Google Scholar 

  • Joos S, Otano-Joos MI, Ziegler S, et al., (1996). Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood, 87:1571–8.

    PubMed  CAS  Google Scholar 

  • Jung M & Dritschilo A. (2001). NF-kappa B signaling pathway as a target for human tumor radiosensitization. Semin Radiat Oncol, 11:346–51.

    PubMed  CAS  Google Scholar 

  • Kalgutkar AS & Zhao Z. (2001). Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents. Curr Drug Targets, 2:79–106.

    PubMed  CAS  Google Scholar 

  • Karin M. (1999). How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene, 18:6867–74.

    PubMed  CAS  Google Scholar 

  • Katsuyama K, Shichiri M, Marumo F, et al., (1998). NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Arterioscler Thromb Vase Biol, 18:1796–802.

    CAS  Google Scholar 

  • Klement JF, Rice NR, Car BD, et al., (1996). IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol, 16:2341–9.

    PubMed  CAS  Google Scholar 

  • Kontgen F, Grumont RJ, Strasser A, et al., (1995). Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev, 9:1965–77.

    PubMed  CAS  Google Scholar 

  • Koong AC, Chen EY & Giaccia AJ. (1994). Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res, 54:1425–30.

    PubMed  CAS  Google Scholar 

  • Kopp E & Ghosh S. (1994). Inhibition of NF-kappa B by sodium salicylate and aspirin. Science, 265:956–9.

    PubMed  CAS  Google Scholar 

  • Kordes U, Krappmann D, Heissmeyer V, et al., (2000). Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia, 14:399–402.

    PubMed  CAS  Google Scholar 

  • Kuo ML, Shen SC, Yang CH, et al., (1998). Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity. Oncogene, 17:2225–34.

    PubMed  CAS  Google Scholar 

  • Kurland JF & Meyn RE. (2001). Protease inhibitors restore radiation-induced apoptosis to Bcl-2-expressing lymphoma cells. Int J Cancer, 96:327–33.

    PubMed  CAS  Google Scholar 

  • Kurland JF, Voehringer DW & Meyn RE. (2003). The MEK/ERK pathway acts upstream of NF kappa Bl (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line. MEK inhibition restores radiation-induced apoptosis. J Biol Chem, 278:32465–70.

    PubMed  CAS  Google Scholar 

  • Lee H, Wu M, La Rosa FA, et al., (1995). Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. Curr Top Microbiol Immunol, 194:247–55.

    PubMed  CAS  Google Scholar 

  • Lentsch AB, Shanley TP, Sarma V, et al., (1997). In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest, 100:2443–8.

    PubMed  CAS  Google Scholar 

  • Lenz HJ. (2003). Clinical update: proteasome inhibitors in solid tumors. Cancer Treat Rev, 29Suppl 1:41–8.

    PubMed  CAS  Google Scholar 

  • Li N and Karin M. (1999). Is NF-kappaB the sensor of oxidative stress? FASEB J, 13: 1137–43.

    PubMed  CAS  Google Scholar 

  • Li ZW, Chu W, Hu Y, et al., (1999). The IKK beta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med, 189:1839–45.

    PubMed  CAS  Google Scholar 

  • Lin YZ, Yao SY, Veach RA, et al., (1995). Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem, 270:14255–8.

    PubMed  CAS  Google Scholar 

  • Ling L, Cao Z & Goeddel DV. (1998). NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc Natl Acad Sci USA, 95:3792–7.

    PubMed  CAS  Google Scholar 

  • Liptay S, Schmid RM, Perkins ND, et al., (1992). Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. Genomics, 13:287–92.

    PubMed  CAS  Google Scholar 

  • Lu D, Thompson JD, Gorski GK, et al., (1991). Alterations at the rel locus in human lymphoma. Oncogene, 6:1235–41.

    PubMed  CAS  Google Scholar 

  • Maggirwar SB, Sarmiere PD, Dewhurst S, et al., (1998). Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J Neurosci, 18:10356–65.

    PubMed  CAS  Google Scholar 

  • Maniatis T. (1999). A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev, 13:505–10.

    PubMed  CAS  Google Scholar 

  • Manna SK & Aggarwal BB. (1998a). IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. J Immunol, 161:2863–72.

    PubMed  CAS  Google Scholar 

  • Manna SK & Aggarwal BB. (1998b). Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13. J Biol Chem, 273:33333–41.

    PubMed  CAS  Google Scholar 

  • Marrogi A, Pass HI, Khan M, et al., (2000). Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. Cancer Res, 60:3696–700.

    PubMed  CAS  Google Scholar 

  • Mathew S, Murty VV, Dalla-Favera R, et al., (1993). Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa B$65, and lyt-10 by fluorescence in situ hybridization. Oncogene, 8:191–3.

    PubMed  CAS  Google Scholar 

  • Matthews JR, Botting CH, Panico M, et al., (1996). Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res, 24:2236–42.

    PubMed  CAS  Google Scholar 

  • May MJ, D’Acquisto F, Madge LA, et al. (2000). Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science, 289:1550–4.

    PubMed  CAS  Google Scholar 

  • Mayo MW, Wang CY, Cogswell PC, et al., (1997). Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science, 278:1812–5.

    PubMed  CAS  Google Scholar 

  • McDade TP, Perugini RA, Vittimberga FJ, Jr., et al., (1999). Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells. Surgery, 126:371–7.

    PubMed  CAS  Google Scholar 

  • Mehta RG, Williamson E, Patel MK, et al., (2000). A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions. J Natl Cancer Inst, 92:418–23.

    PubMed  CAS  Google Scholar 

  • Mercurio F & Manning AM. (1999). NF-kappaB as a primary regulator of the stress response. Oncogene, 18:6163–71.

    PubMed  CAS  Google Scholar 

  • Milas I, Komaki R, Hachiya T, et al., (2003a). Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. Clin Cancer Res, 9:1070–6.

    PubMed  CAS  Google Scholar 

  • Milas L, Mason KA, Crane CH, et al., (2003b). Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme. Oncology (Huntingt), 17:15–24.

    PubMed  Google Scholar 

  • Milas L, Mason KA, Liao Z, et al., (2003c). Chemoradiotherapy: emerging treatment improvement strategies. Head Neck, 25:152–67.

    PubMed  Google Scholar 

  • Mitchell BS. (2003). The proteasome—an emerging therapeutic target in cancer. N Engl J Med, 348:2597–8.

    PubMed  Google Scholar 

  • Mori N, Nunokawa Y, Yamada Y, et al., (1999). Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. Blood, 94:2862–70.

    PubMed  CAS  Google Scholar 

  • Motokura T & Arnold A. (1993). PRADl/cyclin Dl proto-oncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer, 7:89–95.

    PubMed  CAS  Google Scholar 

  • Mukhopadhyay T, Roth JA & Maxwell SA. (1995). Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. Oncogene, 11:999–1003.

    PubMed  CAS  Google Scholar 

  • Nakshatri H, Bhat-Nakshatri P, Martin DA, et al., (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol, 17:3629–39.

    PubMed  CAS  Google Scholar 

  • Natarajan K, Singh S, Burke TR, Jr., et al., (1996). Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA, 93:9090–5.

    PubMed  CAS  Google Scholar 

  • Neubauer H, Cumano A, Muller M, et al., (1998). Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell, 93:397–409.

    PubMed  CAS  Google Scholar 

  • Newton TR, Patel NM, Bhat-Nakshatri P, et al., (1999). Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbetal in breast cancer cells. J Biol Chem, 274:18827–35.

    PubMed  CAS  Google Scholar 

  • O’Connell MA, Cleere R, Long A, et al., (1995). Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78. J Biol Chem, 270:7399–404.

    PubMed  CAS  Google Scholar 

  • Ondrey FG, Dong G, Sunwoo J, et al., (1999). Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog, 26:119–29.

    PubMed  CAS  Google Scholar 

  • Oyaizu H, Adachi Y, Okumura T, et al., (2001). Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line. Oncol Rep, 8:825–9.

    PubMed  CAS  Google Scholar 

  • Oyama T, Ran S, Ishida T, et al., (1998). Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol, 160:1224–32.

    PubMed  CAS  Google Scholar 

  • Pahl HL. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18:6853–66.

    PubMed  CAS  Google Scholar 

  • Pahl HL, Krauss B, Schulze-Osthoff K, et al., (1996). The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med, 183:1829–40.

    PubMed  CAS  Google Scholar 

  • Palayoor ST, Bump EA, Calderwood SK, et al., (1998). Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin Cancer Res, 4:763–71.

    PubMed  CAS  Google Scholar 

  • Palayoor ST, Youmell MY, Calderwood SK, et al., (1999). Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene, 18:7389–94.

    PubMed  CAS  Google Scholar 

  • Palombella VJ, Rando OJ, Goldberg AL, et al., (1994). The ubiquitin-proteasome pathway is required for processing the NF-kappa Bl precursor protein and the activation of NF-kappa B. Cell, 78:773–85.

    PubMed  CAS  Google Scholar 

  • Parganas E, Wang D, Stravopodis D, et al., (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93:385–95.

    PubMed  CAS  Google Scholar 

  • Patel NM, Nozaki S, Shortle NH, et al., (2000). Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene, 19:4159–69.

    PubMed  CAS  Google Scholar 

  • Phillips AC, Ernst MK, Bates S, et al., (1999). E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell, 4:771–81.

    PubMed  CAS  Google Scholar 

  • Pieper GM & Riaz ul H. (1997). Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol, 30:528–32.

    PubMed  CAS  Google Scholar 

  • Qin JZ, Chaturvedi V, Denning MF, et al., (1999). Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem, 274:37957–64.

    PubMed  CAS  Google Scholar 

  • Raju U, Gumin GJ, Noel F, et al., (1998). IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells. Int J Radiat Biol, 74:617–24.

    PubMed  CAS  Google Scholar 

  • Rao PH, Houldsworth J, Dyomina K, et al., (1998). Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood, 92:234–40.

    PubMed  CAS  Google Scholar 

  • Ravi R, Mookerjee B, van Hensbergen Y, et al., (1998). p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res, 58:4531–6.

    PubMed  CAS  Google Scholar 

  • Rayet B & Gelinas C. (1999). Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18:6938–47.

    PubMed  CAS  Google Scholar 

  • Regnier CH, Song HY, Gao X, et al., (1997). Identification and characterization of an IkappaB kinase. Cell, 90:373–83.

    PubMed  CAS  Google Scholar 

  • Rossi A, Elia G & Santoro MG. (1997). Inhibition of nuclear factor kappa B by prostaglandin Al: an effect associated with heat shock transcription factor activation. Proc Natl Acad Sci USA, 94:746–50.

    PubMed  CAS  Google Scholar 

  • Rothe M, Xiong J, Shu HB, et al., (1996). I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA, 93:8241–6.

    PubMed  CAS  Google Scholar 

  • Rothwarf DM, Zandi E, Natoli G, et al., (1998). IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature, 395:297–300.

    PubMed  CAS  Google Scholar 

  • Russell JS, Raju U, Gumin GJ, et al., (2002). Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization. Cancer Res, 62:2318–26.

    PubMed  CAS  Google Scholar 

  • Russo SM, Tepper JE, Baldwin AS, Jr., et al., (2001). Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys, 50:183–93.

    PubMed  CAS  Google Scholar 

  • Ryan KM, Ernst MK, Rice NR, et al., (2000). Role of NF-kappaB in p53-mediated programmed cell death. Nature, 404:892–7.

    PubMed  CAS  Google Scholar 

  • Schesser K, Spiik AK, Dukuzumuremyi JM, et al., (1998). The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol, 28:1067–79.

    PubMed  CAS  Google Scholar 

  • Schmidt-Supprian M, Bloch W, Courtois G, et al., (2000). NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell, 5:981–92.

    PubMed  CAS  Google Scholar 

  • Schneider A, Martin-Villalba A, Weih F, et al., (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med, 5:554–9.

    PubMed  CAS  Google Scholar 

  • Schreck R, Meier B, Mannel DN, et al., (1992). Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med, 175:1181–94.

    PubMed  CAS  Google Scholar 

  • Sen R & Baltimore D. (1986). Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell, 47:921–8.

    PubMed  CAS  Google Scholar 

  • Senftleben U, Cao Y, Xiao G, et al., (2001a). Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science, 293:1495–9.

    PubMed  CAS  Google Scholar 

  • Senftleben U, Li ZW, Baud V, et al., (2001b). IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity, 14:217–30.

    PubMed  CAS  Google Scholar 

  • Shattuck-Brandt RL & Richmond A. (1997). Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. Cancer Res, 57:3032–9.

    PubMed  CAS  Google Scholar 

  • Shoji S, Furuishi K, Ogata A, et al., (1998). An allosteric drug, o,o’-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. Biochem Biophys Res Commun, 249:745–53.

    PubMed  CAS  Google Scholar 

  • Shrivastava A, Manna SK, Ray R, et al., (1998). Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol, 72:9722–8.

    PubMed  CAS  Google Scholar 

  • Shumilla JA, Wetterhahn KE & Barchowsky A. (1998). Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch Biochem Biophys, 349:356–62.

    PubMed  CAS  Google Scholar 

  • Singh S & Aggarwal BB. (1995a). Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem, 270:24995–5000.

    PubMed  CAS  Google Scholar 

  • Singh S & Aggarwal BB. (1995b). Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B. J Biol Chem, 270:10631–9.

    PubMed  CAS  Google Scholar 

  • Singh S, Darnay BG & Aggarwal BB. (1996a). Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation. J Biol Chem, 271:31049–54.

    PubMed  CAS  Google Scholar 

  • Singh S, Natarajan K & Aggarwal BB. (1996b). Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol, 157:4412–20.

    PubMed  CAS  Google Scholar 

  • Snapper CM, Zelazowski P, Rosas FR, et al., (1996). B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol, 156:183–91.

    PubMed  CAS  Google Scholar 

  • Sommer SS, Jiang Z, Feng J, et al., (2003). ATM missense mutations are frequent inpatients with breast cancer. Cancer Genet Cytogenet, 145:115–20.

    PubMed  CAS  Google Scholar 

  • Song HY, Regnier CH, Kirschning CJ, et al., (1997). Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA, 94:9792–6.

    PubMed  CAS  Google Scholar 

  • Sovak MA, Bellas RE, Kim DW, et al., (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest, 100:2952–60.

    PubMed  CAS  Google Scholar 

  • Staal FJ, Roederer M, Raju PA, et al., (1993). Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses, 9:299–306.

    PubMed  CAS  Google Scholar 

  • Strieter RM. (2001). Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol, 2:285–6.

    PubMed  CAS  Google Scholar 

  • Sumitomo M, Tachibana M, Nakashima J, et al., (1999a). An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J Urol, 161:674–9.

    PubMed  CAS  Google Scholar 

  • Sumitomo M, Tachibana M, Ozu C, et al., (1999b). Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. Hum Gene Ther, 10:37–47.

    PubMed  CAS  Google Scholar 

  • Takeda K, Takeuchi O, Tsujimura T, et al., (1999). Limb and skin abnormalities in mice lacking IKKalpha. Science, 284:313–6.

    PubMed  CAS  Google Scholar 

  • Tanaka M, Fuentes ME, Yamaguchi K, et al., (1999). Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity, 10:421–9.

    PubMed  CAS  Google Scholar 

  • Teicher BA, Ara G, Herbst R, et al., (1999). The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res, 5:2638–45.

    PubMed  CAS  Google Scholar 

  • Trecca D, Guerrini L, Fracchiolla NS, et al., (1997). Identification of a tumor-associated mutant form of the NF-kappaB RelA gene with reduced DNA-binding and transactivating activities. Oncogene, 14:791–9.

    PubMed  CAS  Google Scholar 

  • Ueda A, Okuda K, Ohno S, et al., (1994). NF-kappa B and Spl regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol, 153:2052–63.

    PubMed  CAS  Google Scholar 

  • Van Antwerp DJ, Martin SJ, Kafri T, et al., (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science, 274:787–9.

    PubMed  Google Scholar 

  • Van Antwerp DJ & Verma IM. (1996). Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol Cell Biol, 16:6037–45.

    PubMed  Google Scholar 

  • van de Stolpe A, Caldenhoven E, Stade BG, et al., (1994). 12-O-tetradecanoylphorbol-13-acetate-and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem, 269:6185–92.

    PubMed  Google Scholar 

  • Verma IM, Stevenson JK, Schwarz EM, et al., (1995). Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev, 9:2723–35.

    PubMed  CAS  Google Scholar 

  • Visconti R, Cerutti J, Battista S, et al., (1997). Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene, 15:1987–94.

    PubMed  CAS  Google Scholar 

  • von Knethen A, Callsen D & Brune B. (1999). Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol, 163:2858–66.

    Google Scholar 

  • Wang CY, Cusack JC, Jr., Liu R, et al., (1999a). Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med, 5:412–7.

    PubMed  Google Scholar 

  • Wang CY, Guttridge DC, Mayo MW, et al., (1999b). NF-kappaB induces expression of the Bcl-2 homologue Al/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol, 19:5923–9.

    PubMed  CAS  Google Scholar 

  • Wang CY, Mayo MW & Baldwin AS, Jr. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274:784–7.

    PubMed  CAS  Google Scholar 

  • Wang W, Abbruzzese JL, Evans DB, et al., (1999c). Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene, 18:4554–63.

    PubMed  CAS  Google Scholar 

  • Weaver KD, Yeyeodu S, Cusack JC, Jr., et al., (2003). Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas. J Neurooncol, 61:187–96.

    PubMed  Google Scholar 

  • Webster GA & Perkins ND. (1999). Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol, 19:3485–95.

    PubMed  CAS  Google Scholar 

  • Weldon CB, Burow ME, Rolfe KW, et al., (2001). NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery, 130:143–50.

    PubMed  CAS  Google Scholar 

  • Whelan J, Ghersa P, Hooft van Huijsduijnen R, et al., (1991). An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res, 19:2645–53.

    PubMed  CAS  Google Scholar 

  • Yamagishi N, Miyakoshi J & Takebe H. (1997). Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. Int J Radiat Biol, 72:157–62.

    PubMed  CAS  Google Scholar 

  • Yang JP, Hori M, Sanda T, et al., (1999a). Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem, 274:15662–70.

    PubMed  CAS  Google Scholar 

  • Yang JP, Hori M, Takahashi N, et al., (1999b). NFC-kappa subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene, 18: 5177–86.

    PubMed  CAS  Google Scholar 

  • Yaron A, Gonen H, Alkalay I, et al. (1997). Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. EMBO J, 16:6486–94.

    PubMed  CAS  Google Scholar 

  • Zandstra PW, Jervis E, Haynes CA, et al., (1999). Concentration-dependent internalization of a cytokine/cytokine receptor complex in human hematopoietic cells. Biotechnol Bioeng, 63:493–501.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anderson Cancer Center, The University of Texas M.D., USA

    Amit K. Garg & Bharat B. Aggarwal

Authors
  1. Amit K. Garg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bharat B. Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada

    Marek Los  & Spencer B. Gibson  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer

About this chapter

Cite this chapter

Garg, A.K., Aggarwal, B.B. (2005). Nuclear Transcription Factor-κB: A Drug Target for all Seasons. In: Los, M., Gibson, S.B. (eds) Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. Springer, Boston, MA. https://doi.org/10.1007/0-387-23695-3_14

Download citation

Publish with us

Policies and ethics

Search

Navigation